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Abstract
Background: Herpes simplex virus type 1 (HSV-1) cause not only mild symptoms but also blindness and
encephalitis. It was previously shown that the immune response against HSV-1 occurs mainly in the trigeminal
ganglia (TG) and that Toll-like receptors 2 and 9 (TLR2/9) are important in mediating this response. It was also
demonstrated that iNOS (nitric oxide synthase) and interleukin 1 beta (IL-1β) play an essential role in the defense
against HSV-1 infection. Importantly, the present work aimed to identify the primary cells responsible for iNOS and
IL-1β production and search for other important molecules and cells that might or might not depend on TLR2/9
receptors to mediate the immune response against HSV-1.
Methods: C57BL/6 (wild type, WT) and TLR2/9−/− mice were infected by the intranasal route with HSV-1 (1 × 106 p.f.u.).
Cells were obtained from the TG and spleen tissues and the profile of immune cells was determined by flow cytometry
in infected and mock infected WT and knockout mice. The percentage of cells producing iNOS, IL-1β, granzyme B and
perforin was also determined by flow cytometry. Chemokine monocyte chemoattractant protein-1 (MCP1) was
measured by Cytometric Bead Array (CBA) in the TG, spleen and lung. Expression of type I interferons (IFNs),
interleukins (IL) 5 and 10, IL-1β and granzyme B were quantified by real time PCR.
Results: The results indicate that dendritic cells (DCs) and monocytes/macrophages (Mo/Mϕ) were the main sources of
IL-1β and iNOS, respectively, which, together with type I IFNs, were essential for the immune response against HSV-1.
Additionally, we showed that granzyme B produced by CD8+ T and NK lymphocytes and MCP-1 were also important
for this immune response. Moreover, our data indicate that the robust production of MCP-1 and granzyme B is either
TLR-independent or down regulated by TLRs and occurs in the TG of TLR2/9−/− infected mice.
Conclusion: Taken together, our data provide strong evidence that the responses mediated by DCs, Mo/Mϕ, NK and
CD8+ T lymphocytes through IL-1β, iNOS and granzyme B production, respectively, together with the production of
type I IFN early in the infection, are crucial to host defense against HSV-1.
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Background
Herpes simplex virus type 1 (HSV-1) usually causes mild
clinical symptoms such as herpes labialis, but in neo-
nates and immunocompromised individuals, HSV-1
could lead to severe ophthalmic and neurologic lesions,
culminating in blindness, encephalitis or even death [1].
HSV-1 establishes a lifelong latent infection in neuronal
cells, predominantly in trigeminal ganglia (TG) [2]. The
innate immune response is generated mainly through
pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs), which are capable of recognizing
pathogen-associated molecular patterns (PAMPs) [3].
Studies have shown that deficiency in some TLRs and
their transducers, such as MyD88 (myeloid differenti-
ation primary response 88) and TRIF (TIR-domain-
containing adapter-inducing interferon-β), can result
in encephalitis and host death [4–9]. Infectious agent
recognition activates TLR-signaling pathways, which
culminate in pro-inflammatory cytokine production
[3, 10, 11]. Among these cytokines, type I interferons
(IFNs) (mainly IFN-α and IFN-β) play an important role
in the innate response to HSV-1, since they stimulate the
expression of many interferon-stimulated genes. This
stimulation results in the production of cytokines, such as
interleukin 1 beta (IL-1β), tumor necrosis factor alpha
(TNF-α), IFN-γ and some chemokines, that lead to the re-
cruitment of innate immune cells to the local site of infec-
tion, ending ultimately in activation of the adaptive
response and infection control [12–16]. The main cells re-
sponsible for this coordinated immune response against
HSV-1 are natural killer (NK), dendritic (DC) and T cells,
mainly CD8+ lymphocytes [10, 11].
Thus, to study the immune response triggered by this
herpesvirus, we used the intranasal model of infection.
This route of infection was an alternative to the labial in-
fection since this method caused lesions in the oral epithe-
lium that resulted, ultimately, in cannibalism among the
animals. As the TG innervates extensive areas of the face
(through branches of the ophthalmic, maxillary and
mandibular nerves), including the oral and nasal region
[17–19], this model of infection maintain the route of
HSV-1 infection and does not cause tissue lesions.
Previous studies from our group showed that the TG,
but not the brain, seem to be the local site where an effi-
cient immune response against HSV-1 occurs [6, 8, 9].
We used the HSV-1 strain EK, which was isolated from
a human case of recurrent oral herpes with blisters.
C57BL/6 intranasally infected with 106 pfu of this strain
show mild signs of infection (fur loss and snout edema)
by the 4th and 5th day after infection. C57BL/6 mice have
a mortality rate of only 10% while TLR2/9−/− mice have
a 100% mortality rate between the 5th and 8th day after
infection with signs of encephalitis (prostration, ruffled
fur, hunched posture, and posterior paw paralysis) [6, 8].
Analysis of the kinetics of viral replication as well as of
some cytokines expression in the TG of C57BL/6 ani-
mals revealed that on the 5th day post infection (5 dpi)
there are peaks of virus multiplication and also of some
pivotal cytokines expression for an efficient immune re-
sponse [8]. These peaks are subsequently accompanied
by a decrease in viral replication as well as in the levels
of cytokines. Additionally, no viral particles were de-
tected in the brains of these animals, showing that they
can control the infection in the TG, not developing en-
cephalitis [8]. For this reason in our model of intranasal
infection we have chosen the 5th day to study the im-
mune response, since, it seems to be the “key” day to
control virus in the TG of C57BL/6 animals in this
model. Thus, immune response analyzes in TLR2/9−/−
animals were also performed on this day as they begin-
ning to die after the 5th day, which suggests that this day
is important for the infection outcome. Moreover, it was
demonstrated that the adaptor molecule MyD88 or the
TLR2 and TLR9 receptors together are crucial to host
survival, since mice deficient in these molecules suc-
cumb to HSV-1 infection with encephalitis, whereas
wild-type (WT) C57BL/6 mice can control the infection
and survive [8, 9]. We have also demonstrated the im-
portant role of macrophages (Mϕ) as iNOS producers in
host defense against HSV-1 [6].
Here, the present work aimed to further study the im-
mune response against HSV-1 by identifying the organs
and cells responsible for producing iNOS, IL-1β and gran-
zyme B in WT mice, together with the early produc-
tion of type I IFN, and comparing them to the
response in TLR2/9−/− mice to identify which molecules
are dependent on TLR2 and TLR9 receptors together and




For virus replication and titration, Vero cells (ATCC) were
maintained in Dulbecco’s Modified Eagle’s Medium
(DMEM) (Sigma) supplemented with 5% heat-inactivated
fetal bovine serum (FBS) (Cultilab, Brazil) and antibiotics
at 5% CO2 and 37 °C.
Virus replication and purification
Cell culture flasks containing cells at 80% confluence
were infected with HSV-1, strain EK [20], which was iso-
lated from a human case of recurrent oral herpes with
blisters, at a multiplicity of infection (m.o.i.) of 0.1. After
virus adsorption for 1 h in DMEM, the cells were main-
tained for 2 days in DMEM supplemented with 2% FBS.
Purification of infectious virus particles was performed
by collecting the supernatant of infected Vero cells. The
supernatants were precipitated by dripping a saturated
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ammonium sulfate solution to yield an ammonium sul-
fate concentration of 60% in the final volume of the mix-
ture. This step occurred on ice under agitation. The
mixture was then centrifuged at 10,415 × g at 4 °C for
30 min. The precipitate was dissolved in 5 mL of 10 mM
Tris-HCl, pH 8.0, and centrifuged in a sucrose gradient
(36%) in an ultracentrifuge at 36,320 × g at 4 °C for 2 h.
The supernatants were carefully removed and the pellet
was dissolved in Tris-HCl 10 mM, pH 8.0.
Animals
The mouse colonies and all experimental procedures were
performed according to the institutional animal care and
use guidelines from CPqRR/FIOCRUZ. The project was
approved by the Ethics Committee in Animal Experimen-
tation (CEUA from CPqRR/FIOCRUZ LW6/11 and LW-
20/15). TLR2 and TLR9 knockout mice (TLR2/9−/−) were
obtained by crossing TLR2−/− and TLR9−/− mice (both
generated at Osaka University, Japan) at the National
Institutes of Health (NIH, USA) and by backcrossing them
to the C57BL/6 background for eight generations. These
mice were kind gifts of Shizuo Akira and Alan Sher, re-
spectively. The C57BL/6 mice used as wild-type (WT)
controls were obtained from the Centro de Pesquisas
Renê Rachou, Oswaldo Cruz Foundation (CPqRR/FIO-
CRUZ) (Belo Horizonte, Minas Gerais, Brazil), where all
of the mice were maintained in a pathogen-free barrier
environment. Six- to 10-week-old male mice were anes-
thetized with ketamine and xylazine. The mice were intra-
nasally infected with 1 × 106 plaque-forming units (p.f.u.)
of purified HSV-1 as described previously [21]. The con-
trol mice were administered phosphate-buffered saline
(PBS). In the experiments in Figs. 1, 2b-c, 3, 4, 6, 7, 8 and
9, the mice were euthanized 5 days after infection, because
a previously performed kinetic analysis of viral growth
and the cytokine response showed that the peak of virus
and cytokine levels occurred on the 5th day after infection
when this multiplicity of infection was used [8].
Intraperitoneal macrophages
Thioglycolate-elicited peritoneal macrophages were obtained
from either C57BL/6 or TLR2/9−/− mice by peritoneal
Fig. 1 DCs and monocyte/macrophage are higher in C57BL/6 infected than in mock-infected mice, differently of TLR2/9−/−. The profile of immune
cells present in the TG and spleen of C57BL/6 (WT) and TLR2/9−/− (KO) mice was assessed by cytometry analysis. Groups of six mice were infected with
106 p.f.u. of HSV-1 via the intranasal route and, on the 5th day post infection, mice were euthanized, and TG and spleen cell suspensions were prepared.
a Frequencies of live leukocytes (CD45+) were analyzed within the population of TG and spleen cells and frequencies of myeloid cells
(CD45+CD3−CD11b+) were analyzed within the population of live leukocytes in the TG and spleen; b CD4 (CD45+CD3+CD4+), CD8 (CD45+CD3+CD8+),
NK T (CD45+CD3+NK1.1+), NK (CD45+NK1.1+), dendritic (DC, CD45+MHC class IIhigh+CD11c+) and monocyte/macrophage (Mo/Mϕ, CD45+F4/80+) cells
were analyzed within the population of live leukocytes in the TG and spleen. A minimum of 100,000 events was acquired for analysis. Bars show the
means ± SEM. * p < 0.05; ** p < 0.01 and *** p < 0.001. White bars: mock-infected mice; black bars: infected mice
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washing. Adherent peritoneal macrophages were cul-
tured in 6-well plates in an atmosphere with 5% CO2
at 37 °C in DMEM supplemented with 5% FBS and antibi-
otics. A group of wells were infected with HSV-1 at a m.o.i.
of 1. A second group was used as a control and did not
receive any stimulus. All wells were then activated with
sub-optimal concentration of murine IFN-γ (20 U/mL). At
different time points (24, 48 and 72 h post infection), the
cells were harvested, and the supernatant was collected and
homogenized in TRIzol Reagent (Invitrogen) for RNA iso-
lation and subsequent reverse transcription (RT) reaction.
RNA extraction and reverse transcription
Five days post infection, for the TG and spleen, and 3hs
and 24hs post infection, for the lung tissues, were
aseptically collected, homogenized in TRIzol (Thermo
Fisher Scientific, USA) and stored at −70 °C until
RNA extraction. RNA extraction was performed ac-
cording to the procedures provided by the manufac-
turer of TRIzol reagent. Total RNA was treated with
DNase (Promega, USA) and subjected to a RT reac-
tion that used M-MLV enzyme (Promega, USA) ac-
cording to the manufacturer's instructions.
Fig. 2 DCs are the major producers of IL-1β in the TG of C57BL/6 mice after infection. a Peritoneal macrophages derived from C57BL/6 (WT) and
TLR2/9−/− (KO) mice were infected with HSV-1 (m.o.i. of 1, 5 wells/group), and the levels of IL-1β mRNA were determined in the supernatants at
different times after infection (as indicated in the figure) by qPCR. The results use arbitrary units for the ratio of target gene mRNA to endogenous
control HPRT mRNA. Data are representative of two independent experiments with similar results. For myeloid cell and DC frequency analyses,
groups of six mice were infected with 106 p.f.u. HSV-1 via the intranasal route and, on the 5th day post infection, mice were euthanized,
and TG and spleen cell suspensions prepared for flow cytometry evaluation. The frequencies of myeloid (CD45+CD3−CD11b+) and dendritic
(CD45+MHC class II high+CD11c+) cells producing IL-1β in the TG (b) and spleen (c) are shown. The frequency of each cell was calculated
within the population of live leukocytes. A minimum of 100,000 events was acquired for analysis. ND: not detected. Bars show the means ± SEM.
* p< 0.05 and ** p< 0.01
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Quantitative PCR (qPCR)
qPCRs were performed to measure mRNA expression in
the TG, lung, spleen tissues and peritoneal macrophages.
The reactions were performed with SYBR Green PCR
Master Mix (Applied Biosystems, USA) in a 7500 real-
time PCR System (Applied Biosystems, USA). Amplifica-
tion was performed with SYBR Green PCR Master Mix
using the following conditions: 95 °C for 10 min,
followed by 50 two-step cycles of 95 °C for 15 s and 60 °
C for 1 min and a final dissociation stage. The qPCR
was performed with oligonucleotide primer pairs specific
for the coding region of hypoxanthine-guanine phos-
phoribosyltransferase (HPRT) (forward: 5’-GTT GGA
TAC AGG CCA GAC TTT GTT G-3’, reverse: 5’-GAT
TCA ACT TGC GCT CAT CTT AGG C-3’); granzyme
B (GRZ-b) (forward: 5’-ACT TTC GAT CAA GGA TCA
GCA-3’, reverse: 5’-GGC CCC CAA AGT GAC ATT
TAT T-3’); IL-10 (forward: 5’-GGT TGC CAA GCC
TTA TCG GA-3’, reverse: 5’-ACC TGC TCC ACT GCC
TTG CT-3’); IL-5 (forward: 5’-ACA GTG GTG AAA
GAG ACC TT-3’, reverse: 5’-TCC AAT GCA TAG CTG
GTG ATT T-3’); chemokine (C-C motif) ligand 2 (CCL-2
or MCP-1) (forward: 5’-CTT CTG GGC CTG CTG TTC
A-3’, reverse: 5’-CCA GCC TAC TCA TTG GGA TCA-3’)
[22]; pro-interleukin 1 beta (pro-IL-1β) (forward: 5’-CGC
AGC AGC ACA TCA ACA AGA GC-3’, reverse: 5’-TGT
CCT CAT CCT GGA AGG TCC ACG-3’); interferon
alpha 4 (IFN-α4) (forward: 5’- ACT CAT TCT GCA ATG
ACC TCC A -3’, reverse: 5’- AGA GGA GGT TCC TGC
ATC ACA -3’) and interferon beta (IFN-β) (forward: 5’-
CTGGAGCAGCTGAATGGAAA-3’, reverse: 5’-TGTCT
GCTGGTGGAGTTCAT-3’). A standard curve was pre-
pared by serial dilution of the amplified DNA for each tar-
get gene. The standard curve method was used to analyze
the data. The mRNA levels of the target genes were nor-
malized to the expression of HPRT, the housekeeping
gene. All reactions were done in duplicate.
Cytokine bead array analysis
MCP-1 levels were measured in TG, lung, spleen and
cervical lymph node tissues using Cytometric Bead
Array kit (CBA, BD Biosciences Pharmingen, USA) ac-
cording to the manufacturer’s instructions. The tissues
from mock infected and infected C57BL/6 and TLR2/
Fig. 3 Monocytes/macrophages are the main iNOS producers in the TG of C57BL/6 mice during HSV-1 infection. Groups of six mice were infected
with 106 p.f.u. HSV-1 via the intranasal route and, on the 5th day post infection, mice were euthanized, and TG and spleen cell suspensions prepared
for cytometry analyses. a Frequencies of iNOS-producing myeloid cell populations (CD45+CD3−CD11b+) within the live leukocyte population. b
Frequencies of iNOS-producing monocytes/macrophages (Mo/Mϕ) (CD45+F4/80+) within the population of live leukocytes in the TG and spleen. A
minimum of 100,000 events was acquired for analysis. KO = TLR2/9−/− mice. White bars: mock-infected mice; black bars: infected mice. Bars show the
means ± SEM. * p < 0.05; ** p < 0.01 and *** p < 0.001
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9−/− mice were homogenized in PBS containing pro-
tease inhibitors (Complete mini [EDTA-free], Roche,
Basel, Switzerland), and the supernatants were used
for cytokine measurements.
Isolation of TG and splenic leukocytes
Single-cell suspensions were harvested from the TG and
spleens of six C57BL/6 and six TLR2/9−/− mock-infected
(PBS) and infected (1x106 p.f.u.) mice, 5 days after infec-
tion. TG were incubated with 2 mg/mL collagenase
(Merck-Chemicals) for 30 min in 5% CO2 at 37 °C.
Single-cell suspensions were prepared by passing the TG
and spleen through a 70-μm nylon cell strainer (BD
Biosciences). Splenocytes were then treated with ACK
lysis buffer (BD Biosciences) on ice for two minutes.
Samples were suspended in complete Roswell Park
Memorial Institute medium (RPMI) and plated for flow
cytometry analysis.
Flow cytometry analysis of cell populations and
intracellular cytokine production
For flow cytometry analysis, BD GolgiPlug Protein Trans-
port Inhibitor (BD Biosciences, San Jose, CA) was added,
and cells were cultured for 10 h in 5% CO2 at 37 °C. After
incubation, cells were washed with FACS buffer (PBS with
2% FBS) and stained with Acqua Live/Dead (Invitrogen,
USA) for 10 min at 4 °C for dead cell exclusion. Cells
were washed and stained for surface molecules for
30 min at 4 °C, fixed and permeabilized according to
the manufacturer’s instructions (Cytofix/Cytoperm,
BD Biosciences, USA). After washing, cells were incu-
bated with antibodies against intracellular antigens for
30 min at 4 °C. Cells were then washed and suspended in
200 μL of FACS buffer for cytometry analysis. Data were
collected using an LSR II (BD Immunocytometry Systems,
USA) with Diva (BD Biosciences, USA). At least 100,000
gated events were acquired. Representative FACS density
plots showing the gate strategy for the identification
of IL-1β within CD11c+MHCIIhigh and iNOS within
F4/80+ gated on live CD45+ leucocytes in the trigemi-
nal ganglia and spleen from a single HSV1-infected
wild type mouse were done on Additional file 1: Figure S1
and Additional file 2: Figure S2, respectively.
The antibody panels used to define the cell subpopula-
tions included the following: anti-CD11c PE-Cy7 (clone
N418), anti-F4/80 eFluor 450 (clone BM8), anti-CD45.2
Alexa Fluor 700 (clone 104), anti-NK1.1 APC-eFluor
780 (clone PK136), anti-IL-1β pro-form APC (clone
NJTEN3), anti-granzyme B PE-Cy7 (clone 16G6) and
anti-perforin FITC (clone eBioOMAK-D), all purchased
from eBioscience, USA; anti-I-4/I-E biotin (clone 2G9),
anti-CD8a PE (clone 53–6.7) and anti-CD3e PerCP
(clone 145-2C11), purchased from BD Pharmingen,
USA; streptavidin Qdot 605 and anti-CD4 Qdot 605
(clone RM4-5), purchased from Invitrogen, USA; anti-
CD11b Brilliant Violet 570 (clone M1/70), purchased from
BioLegend, USA; and anti-iNOS/NOS Type II FITC (clone
6/iNOS/NOS Type II), purchased from BD Transduction
Laboratories, USA. Data were analyzed with FlowJo (Tree
Star) software. The expression of myeloid markers was ana-
lyzed after gating on CD45+CD3− live cells.
Statistical analysis
The statistical analyses were performed using GraphPad
Prism 5 software for Windows (GraphPad Software, Inc.,
La Jolla, CA, USA). The sample groups were assessed by
non-parametric or parametric tests depending on
Kolmogorov-Smirnov normality. The Mann–Whitney
test was used for nonparametric data, and an unpaired T
test was used for parametric data.
Results
More dendritic cells and monocytes/macrophages are
present in the TG of infected WT mice than mock-infected
WT mice, in contrast to TLR2/9−/− mice
Cell population profiles in the TG and spleen of C57BL/
6 and TLR2/9−/− mice were analyzed without infection
and on the 5th day of HSV-1 infection using flow cytom-
etry (Fig. 1). The percentage (%) of leukocytes (CD45+)
and myeloid cells (CD45+CD3−CD11b+) increased in the
TG of WT and TLR2/9−/− mice after HSV-1 infection
(Fig. 1a). In the spleen, the % of myeloid cells was also
larger in the infected groups. However, the global
leukocyte % decreased in the spleen in both groups after
Fig. 4 IFN-β expression occurs in the TG of both WT and TLR2/9−/−
animals after HSV-1 infection. Mice were infected with 106 p.f.u. of
HSV-1, euthanized on the 5th day post infection, and the TGs were
collected for mRNAs expression analysis by qPCR. The results use
arbitrary units for the ratio of target gene mRNA to endogenous
control HPRT mRNA. Data are representative of two independent
experiments with similar results. KO = TLR2/9−/− mice. Bars show the
means ± SEM. * p < 0.05. n = 4–8 mice/group
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infection (Fig. 1a). Further analysis of the cell profile in
the TG showed that the % of DCs and Mo/Mϕ was lar-
ger in infected WT mice than in mock-infected WT
mice, while there were no significant alterations in the
presence of these two cell types in infected and mock-
infected TLR2/9−/− mice (Fig. 1b). The % of CD4+ T and
CD8+ T lymphocytes present did not differ significantly
in infected and mock-infected WT mice, whereas these
cell populations were larger in infected than mock-
infected TLR2/9−/− mice. In contrast, the % of NK T
cells in the TG was smaller in infected than mock-
infected TLR2/9−/− mice, whereas the WT mice pre-
sented no significant difference in the % of this cell
population in infected and mock-infected mice. The NK
cells in the TG presented the same profile in WT and
TLR2/9−/− infected and mock-infected mice. In the spleen,
the % of DCs and CD4+ T lymphocytes was smaller in in-
fected than in mock-infected WT and TLR2/9−/− mice.
The % of CD8+ T lymphocytes was lower in the spleen of
infected than mock-infected TLR2/9−/− mice, but the pro-
file of CD8+ T lymphocytes in the spleen of infected and
mock-infected WT mice was similar. The number of NK
T cells in the spleen did not change significantly with the
infection of WTand TLR2/9−/− animals, although the per-
centage of NK Tcells in infected WT mice was larger than
that in the TLR2/9−/− mice. There were more NK cells in
infected than mock-infected TLR2/9−/− mice, while there
was no difference between infected and mock-infected
WT mice. Finally, in the spleen, there was a lower % of
Mo/Mϕ in the mock-infected mice than in the infected
WTand TLR2/9−/− mice.
Dendritic cells are the main producers of IL-1β in the TG
and are crucial for HSV-1 defense
The kinetics of IL-1β mRNA transcription in peritoneal
Mϕ from WT and TLR2/9−/− mice were analyzed by
qPCR at different time points following in vitro infection
(Fig. 2a). Prior to infection, IL-1β mRNA was not de-
tected in peritoneal Mϕ from either group of animals.
Following infection, Mϕ derived from WT mice exhib-
ited a higher mRNA level of IL-1β 48 and 72 h post in-
fection, while the IL-1β mRNA level from the TLR2/9−/−
mice showed a slight increase with a peak at 48 h of in-
fection; however, this level was lower than that in the
WT mice and was followed by a decrease at the next
time point. These results showed that the absence of
TLR2 and TLR9 has a strong negative effect on IL-1β
mRNA level. Thus, to identify the major IL-1β-producing
cell in the TG and spleen of WT and TLR2/9−/− mice, we
performed flow cytometry analysis (Fig. 2b, c and
Additional file 1: Figure S1). Our data showed that
the main IL-1β response against infection occurs in
the TG (Fig. 2b, left and Additional file 1: Figure S1a), as
indicated by the high % of cells producing this cytokine in
this tissue (with no significant differential detection in the
spleen) (Fig. 2c and Additional file 1: Figure S1b) and that
myeloid cells derived from TLR2/9−/− mice were unable
to produce this cytokine, as shown by the impaired pro-
duction in the TG observed in mock-infected and infected
mice (Fig. 2b, left). Since no detectable production of IL-
1β by myeloid cells was seen in the TG of TLR2/9−/− mice,
we performed the subsequently analysis (Fig. 2b, right)
only in the WT group. Thus, among the cell populations
evaluated, it was discovered that DCs (Fig. 2b, right) are
the major cell producing IL-1β in the TG during infection.
Monocytes/macrophages are the most important
producer of iNOS and have a pivotal role against HSV-1
To determine the primary tissue producing iNOS, which
is essential for establishing an efficient immune response
against HSV-1, a previous study from our group evalu-
ated the levels of iNOS in the TG and brain of WT and
TLR2/9−/− mice through qPCR and an immunofluores-
cence assay. The data suggested that iNOS is expressed
in a TLR-dependent manner and identified Mo/Mϕ as
the primary iNOS-producing cells important for mouse
survival [6]. Thus, to evaluate the production of iNOS
at the local and systemic levels and identify other
types of cells producing this molecule, we checked
iNOS production in the TG and spleen of WT and
TLR2/9−/− mice through flow cytometry analysis
(Fig. 3a, b and Additional file 2: Figure S2).
Our results showed an increase in the % of myeloid
cells producing iNOS in the TG of infected WT mice;
this was unlike in TLR2/9−/− mice, which exhibited no
statistically difference in the % of cells producing this
molecule during infection (Fig. 3a, left). On the other
hand, spleens from both WT and TLR2/9−/− infected
mice presented a reduction in the % of myeloid cells
producing iNOS (Fig. 3a, right). In addition, a greater
percentage of iNOS-producing Mo/Mϕ was found in
the TG of WT mice during infection compared to
TLR2/9−/− infected mice (Fig. 3b and Additional file 2:
Figure S2a). The spleens from WTand TLR2/9−/− infected
mice presented similar profile of Mo/Mϕ producing iNOS
(Fig. 3b and Additional file 2: Figure S2b).
Type I interferon expression in the TG is higher in
infected than in mock-infected WT and TLR2/9−/− animals
5 days after infection
The mRNA expression level of type I IFNs during HSV-1
infection was evaluated in the TG of WT and TLR2/9−/−
mice on the 5th day after infection using qPCR. In the TG
of both the WT and TLR2/9−/− infected groups, the levels
of IFN-β mRNA increased relative to their respective
control groups (Fig. 4). Nevertheless, no difference was ob-
served between WT and TLR2/9−/− infected mice. As the
virus was administered intranasally and type I IFNs are
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generally expressed earlier, we also decided to evaluate their
expression in the first few hours of infection in the lungs.
The expression of Type I interferons in the first 3 and 24 h
after infection in the lung, in contrast, is higher only in the
WT animals
The expression of type I IFNs mRNA in the lungs was
measured 3 and 24 h after infection. The WT mice
showed an increase in IFN-β mRNA level, which reached
a higher level of expression at 24 h post infection, while
the TLR2/9−/− mice exhibited a marked decrease in the
mRNA level of this cytokine at this time (Fig. 5a). A simi-
lar pattern in mRNA levels was also observed for IFN-α4
in the lungs of WTand TLR2/9−/− infected mice (Fig. 5b).
Infected mice generate more MCP-1 in the trigeminal
ganglia and spleen than mock-infected mice
As reported previously, during HSV-1 infection, the che-
mokine MCP-1 is overexpressed in the TG of TLR2/9−/−
infected mice [8]. Thus, to better understand how the
response of this protein occurs, MCP-1 expression and
production in the TG, spleen and lung was evaluated.
A higher level of MCP-1 was produced in the TG and
spleen of WT infected mice relative to mock-infected
mice. Higher production of MCP-1 was observed in the
TLR2/9−/− infected mice relative to WT infected mice
(Fig. 6a). The same production profile was observed in
the spleen (Fig. 6b). In the lung, the infected TLR2/9−/−
mice showed higher levels of MCP-1 than the mock-
infected TLR2/9−/− mice, whereas in WT mice, there
was no differential production of this protein (Fig. 6c).
Granzyme B is produced by CD8+ T and NK lymphocytes
To better understand the mechanism underlying the
immune response against HSV-1, the role of granzyme
B during HSV-1 infection was also evaluated (Fig. 7).
Therefore, we evaluated the mRNA levels of granzyme B
in the TG and spleen of WT and TLR2/9−/− mice and
identified the cell types producing this molecule in these
tissues during HSV-1 infection.
The mRNA level of granzyme B in the TG and spleen
of infected mice was higher than that in mock-infected
animals for both the WT and the TLR2/9−/− animals, al-
though the mRNA level in the infected TLR2/9−/− mice
was much higher than that in the WT mice (Fig. 7a).
Thus, the next step was to identify the cells responsible
for granzyme B production. Although the production of
granzyme B in the spleen of WT infected compared to
mock infected animals occurred distinctly only by NK
cells, this molecule was also produced by other popula-
tion of cells, though there was no statistical difference
between the mock-infected and infected groups (Fig. 7c-f,
right). The same was observed in the trigeminal ganglia
(Fig. 7c-f, left). In this case, the production of granzyme B
in WT animals occurred mainly through NK and CD8+
cells (Fig. 7e and f, left). However, in the TLR2/9−/− mice,
several cell types in the spleen, such as CD4+, CD8+,
NK T and NK cells, produced granzyme B when we
compared infected and mock-infected mice (Fig. 7c-f,
right). Furthermore, analysis of a gate containing all
granzyme B-positive cells confirmed that TG cells
from TLR2/9−/− mice not only show higher mRNA
levels but also produce more granzyme B than WT
mice, as observed for the spleen (Fig. 7b).
CD8+ T lymphocytes are the main cell producing perforin
in the spleen, while the perforin produced in the TG
seems to be irrelevant
Furthermore, the production of perforin was evaluated
after HSV-1 infection. A comparison of the infected and
mock-infected WT and TLR2/9−/− groups showed that
the overall production of perforin in the TG by several
Fig. 5 Earlier type I IFN expression in the lung occurs in WT infected animals. Mice were infected with 106 p.f.u. of HSV-1, euthanized, and lung
tissues were collected for mRNAs expression analysis by qPCR. IFN-β (a) and IFN-α4 (b) mRNAs level in the lung 3 or 24 h after infection. Mock-infected =
animals that inhaled PBS. The results use arbitrary units for the ratio of target gene mRNA to endogenous control HPRT mRNA. Data are representative of
two independent experiments with similar results. KO = TLR2/9−/− mice. Bars show the means ± SEM. * p< 0.05; ** p < 0.01 and *** p < 0.001.
n= 7–11 mice/group
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cell types (such as CD4+, CD8+, NK T and NK cells) was
not statistically significant during infection (Fig. 8a-d).
However, in the spleen, CD8+ T lymphocytes from the
infected mice produced more perforin than the mock-
infected cells. Additionally, the infected TLR2/9−/− mice
produced more perforin than the infected wild-type
mice (Fig. 8b, right).
TLR2/9−/− mice exhibit a mix of Th1 and Th2 immune
responses
Therefore, realizing that TLR2/9−/− mice were less ef-
fective in protecting against HSV-1 [8] and that they
produced less IL-1β and iNOS, typical molecules in the
Th1 immune response, we analyzed the mRNA levels of
IL-10, a regulatory cytokine in the immune response,
and IL-5, an important component of the Th2 immune
response, on the 5th day post infection using qPCR. The
infected WT mice exhibited a lower level of IL-5 mRNA
and a higher level of IL-10 mRNA than the mock-
infected WT mice but a much lower mRNA level of IL-
10 than the infected TLR2/9−/− mice.
Surprisingly, the TLR2/9−/− infected mice exhibited an
exacerbated response with regard to these two cytokines,
indicating that a strong regulatory response was possibly
being mediated by IL-10 due to the increased mRNA
levels of chemokines in the TLR2/9−/− mice (Fig. 9a).
Additionally, a Th2-skewed response also occurred in
the TLR2/9−/− mice, which exhibited higher levels of
IL-5 mRNA (Fig. 9b), suggesting a mixed Th1 and
Th2 immune response in the TLR2/9−/− mice.
Discussion
Several studies have attempted to understand the main
mechanisms involved in the immune response and iden-
tify the key components responsible for the recognition
and establishment of an efficient immune response
against HSV-1 [9, 15, 23–26]. Data from our group and
from other studies have highlighted the key role of TLR2
and TLR9 in the recognition and activation of the im-
mune response against HSV-1 infection and have sug-
gested synergistic action of these receptors in the
establishment of an effective response, since all the WT
animals survive the infection, while all the TLR2/9−/−
mice die after infection [6, 8, 27, 28]. Furthermore, our
group discovered that this immune response is mainly
localized in the TG with the important role of the
MyD88 adapter molecule along with IFN-γ and iNOS
during infection. In the TG, after infection, a viral tran-
script and viral protein were identified [6, 8, 9]. Thus,
continuing our studies, this work attempted to extend
our knowledge of the immune response against HSV-1
by identifying the immune cells involved and the
Fig. 6 MCP-1 levels are higher in the TG and spleen of infected animals than mock-infected animals. C57BL/6 (WT) and TLR2/9−/− (KO) mice were
infected with 106 p.f.u. of HSV-1, and the chemokine levels were determined in tissue homogenates with a bead-based immunoassay. a MCP-1
measured in the TG. b MCP-1 in the spleen. c MCP-1 in the lung. These experiments are representative of three independents experiments with
similar results. White bars: mock-infected groups. Black bars: infected groups. Bars show means ± SEM. * p < 0.05 and ** p < 0.01
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molecules produced as a result of their activation to ob-
tain an effective response.
We showed that the % of Mo/Mϕ and DCs are higher
in the TG of infected than mock-infected WT mice
(Fig. 1b), which differs from what occurs in TLR2/9−/−
mice. These leukocytes are important components of the
innate immune system as they play a crucial role in acti-
vating the antiviral cell-mediated immune response and
also in producing important immune mediators [29–31].
During HSV-1 primary infection they act limiting viral
replication and maintaining the latency state but also,
activating the adaptive immune response [32]. Macro-
phages are especially important in phagocyte infected
and apoptotic cells but also through the release of
pro-inflammatory cytokines, as well as other immune
mediators such as nitric oxide [33, 34]. Dendritic
cells, in turn, are crucial for antigen presentation and,
thus, trigger the adaptive immune response as was
previously reported [35–38].
Furthermore, we showed that both the IL-1β mRNA
[8] and protein level (Fig. 2b) are higher in the TG of in-
fected than mock-infected WT mice. There was a drastic
decrease in IL-1β in TLR2/9−/− mice (Fig. 2b). This
shows that IL-1β production is probably not down mod-
ulated by viral post-transcriptional modification, since
HSV-1 is a complex virus with several evasion mecha-
nisms, including inhibition of the translation of host
proteins [39–41]. Importantly, it was discovered that
among the studied cells, DCs in the TG of WT mice
were the major cells producing IL-1β (Fig. 2b and
Additional file 1: Figure S1a). As IL-1β is a cytokine with
a major role to initiate the inflammatory process after an
infection [42–44], this was also showed during the HSV-
1 infection. Likewise, previous studies revealed that IL-
Fig. 7 Granzyme B is produced in the TG of C57BL/6 mice by CD8+ T/NK after infection. a The GRZ-b mRNA level was measured in TG and spleen
homogenates from C57BL/6 (WT) and TLR2/9−/− (KO) mice on the 5th day post infection (106 p.f.u. of HSV-1) by qPCR. Data are representative of
two independent experiments with similar results (n = 9–19 mice/group). The frequencies of GRZ-b-producing cells within the population of live
leukocytes were analyzed by flow cytometry in the TG and the spleen b–f (6 animals per group). b GRZ-b+ NK T cells (CD45+CD3+NK1.1+);
c GRZ-b+ CD4+ T cells (CD45+CD3+CD4+); d NK cells (CD45+NK1.1+); e GRZ-b+ CD8+ T cells (CD45+CD3+CD8+) and f GRZ-b+ live leucocytes
(CD45+GRZb+). A minimum of 100,000 events was acquired for analysis. White bars: mock-infected groups. Black bars: infected groups. ND: not
detected. Bars show the means ± SEM. * p < 0.05; ** p < 0.01 and *** p < 0.001
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1β deficiency is lethal to mice and demonstrated its im-
portant role in repairing pathological insults due to
HSV-1 infection within the central nervous system [45, 46].
In TLR2/9−/− mice the decreased IL-1β level could be one
of the reasons for their highly mortality [8].
Zolini and collaborators (2014) [6], in addition to
highlighting the TLR-dependence, showed that macrophages
are the producers of iNOS, an important host defense
protein [47, 48] in the TG. We confirmed that Mo/
Mϕ were the primary iNOS-producing cells (Fig. 3a, b
and Additional file 2: Figure S2) in the TG and that DCs
were not good producers of iNOS. Other studies have also
highlighted the important role of this molecule in host
defense and indicate Mϕ as the main source, which is in
line with our results [33, 34, 49, 50]. In other words, IL-1β
together with iNOS is essential in mediating the local
Fig. 8 Perforin is produced by CD8+ T lymphocytes in the spleen of C57BL/6 mice after infection. Groups of C57BL/6 (WT) and TLR2/9−/− (KO)
mice (6 animals/group) were infected with 106 p.f.u. HSV-1 via the intranasal route and, on the 5th day post infection, mice were euthanized, and
TG and spleen cell suspensions prepared for flow cytometry analysis. The frequency of each cell within the live leukocyte population was determined.
a Frequencies of perforin-producing CD4+ T cells (CD45+CD3+CD4+); b CD8+ T cells (CD45+CD3+CD8+); c NK T cells (CD45+CD3+NK1.1+) and d NK cells
(CD45+NK1.1+). A minimum of 100,000 events was acquired for analysis. White bars: mock-infected mice; black bars: infected mice. Bars show the
means ± SEM. * p < 0.05; ** p < 0.01 and *** p < 0.001
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(TG), but not systemic (spleen), immune response against
HSV-1. Additionally, these two molecules are TLR2/9
dependent, as TLR2/9−/− mice produce them at low levels
(Figs. 2 and 3), and, in contrast to WT mice, these mice
died after infection [8].
IFN-β transcript, however, is detected in both WT and
TLR2/9−/− mice in the TG on the 5th day after infection
(Fig. 4), indicating that this response seems to be TLR-
independent. However, at the beginning of the infection,
the type I IFN (IFN-α and IFN-β) mRNA levels in the
lung of WT mice were higher than those in the infected
TLR2/9−/− mice (Fig. 5a, b). As the response of these cy-
tokines occurs early during a viral infection, their mRNA
levels were down regulated in the lungs of TLR2/9−/−
mice in the first hours after intranasal infection. In other
studies [32, 51–54] it was demonstrated that type I IFNs
certainly play an essential role in the immune response
in restricting viral infections and shaping the adaptive
immune response.
Down regulation of the levels of IL-1β and iNOS in
TG occurs simultaneously with overexpression of other
molecules as MCP-1 and granzyme B in TLR2/9−/− in-
fected mice. The increase in MCP-1 mRNA levels after
HSV-1 infection was already observed in the TG of
TLR2/9−/− mice in our previous study [8]; however, in
the present work, the increase in MCP-1 was confirmed
at the protein level in the TG and spleen as well (Fig. 6a, b).
Thus, MCP-1 seems not to depend on TLRs to be
expressed/produced. Alternatively, MCP-1 down regulation
could depend on these receptors, since its mRNA and
protein levels are higher in TLR2/9−/− mice than WT
mice after infection. As MCP-1 attracts monocytes,
basophils, NK and T cells, its presence at these initial
sites of HSV-1 infection could play a role in preventing
the spread of virus to neighboring tissues [55], but these
cells in TLR2/9−/− mice lack functional TLR2 and TLR9,
resulting in nonfunctional cells and in a nonfunctional
immune response. Several studies have highlighted the
relevance of MCP-1 in mediating the immune response
against HSV-1, however its exactly role is not yet com-
pletely understood [25, 56–59].
Since our previous studies have indicated the import-
ance of IFN-γ-producing CD8+ T cells in the control of
HSV-1 infection in WT mice [8], we decided to evaluate
the role of the granzyme B and perforin molecules and
identify the primary cells producing these molecules.
Notably, granzyme B (a serine protease) and perforin (a
pore-forming protein) are important components of the
immune response, as they confer the cytotoxic activity
of NK cells and CD8+ T lymphocytes [60–62]. Moreover,
these molecules, when released within the target cell,
cause DNA fragmentation and rapid loss of membrane
integrity, leading to cell apoptosis and, consequently,
viral clearance [63, 64]. It was shown that granzyme B
mRNA levels in the TG and spleen of infected WT mice
were higher than those in mock-infected animals
(Fig. 7a). The TLR2/9−/− infected mice also showed a
higher mRNA level of granzyme B than mock-infected
mice and even a higher level than the WT mice. Thus,
this high level of granzyme B in TLR2/9−/− mice to-
gether with lower production of IL-1β and iNOS is not
sufficient to control the infection, resulting in mortality
(as reported in [8]). It was shown that among the studied
cells, NK and CD8+ T cells are the major cells producing
granzyme B in the TG, while in the spleen only the NK
cells produced it (Fig. 7e, f ). In TLR2/9−/− mice TG large
amount of granzyme B was produced by NK T, NK
and CD8+ cells after infection (Fig. 7c, e-f). The produc-
tion of granzyme B by NK T cells from the spleen of
TLR2/9−/− mice was even higher than that observed in the
WT mice (Fig. 7c). In a more general analysis of the
number of leukocytes producing granzyme B in the
TG and spleen in the WT and TLR2/9−/− infected
mice, the production of granzyme B was higher in
Fig. 9 The immune response in TLR2/9−/− mice appears to be a mix of Th1/ Th2 response. IL-10 a and IL-5 b mRNAs levels were measured in
TG homogenates from C57BL/6 (WT) and TLR2/9−/− (KO) mice on day 5 post infection (106 p.f.u. of HSV-1) by qPCR. The expression results use
arbitrary units for the ratio of target gene mRNA to the endogenous control, HPRT. Data are representative of two independent experiments
with similar results. n = 9–19 mice/group. White bars: mock-infected groups. Black bars: infected groups. Bars show the means ± SEM. * p < 0.05;
** p < 0.01 and *** p < 0.001
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the TLR2/9−/− mice than in the WT mice (Fig. 7b).
Thus, in the WT infected mice, granzyme B could be
mediating cell cytotoxic activity, regulating the im-
mune response and interfering in HSV-1 reactivation
in the TG, as previously evidenced in other studies
[61, 65–67]. In contrast, in the infected TLR2/9−/−
mice, the high level of granzyme B could be contrib-
uting to an exacerbated immune response and the
pathogenesis of the infection, contributing to animal
death [68]. However, the regulation of perforin is dif-
ferent, with consistent basal production by all tested
cells (CD4+, CD8+, NK T and NK cells) in the TG of
mock-infected WT mice (Fig. 8a-d, left). This was
also observed in the TG of TLR2/9−/− mice (Fig. 8a-
d, left). However, in the spleen, perforin was differen-
tially produced by CD8+ T cells, which exhibited an
increased % of perforin-positive cells after HSV-1 in-
fection in both WT and TLR2/9−/− mice (Fig. 8b,
right). Thus, in the TG of WT mice, the basal levels
of perforin seemed to be sufficient for its role in me-
diating cytotoxicity activity [63, 69, 70], or if the release of
granzyme B occurs in a perforin-independent manner,
it would not be necessarily functional [63, 71, 72].
However, in the TLR2/9−/− mice, perforin possibly
was not acting in viral clearance but contributing to
the immunopathogenesis of infection, as previously
described [63, 73, 74].
Another remarkable finding was that the IL-10 mRNA
levels, which plays an important role in controlling the
levels of pro-inflammatory cytokines [75–77] were
higher in the TG of both WT and TLR2/9−/− mice after
HSV-1 infection (Fig. 9a). The mRNA levels were even
higher in the TLR2/9−/− mice than in the WT mice.
Thus, IL-10 does not seem to depend on TLRs to in-
crease its mRNA levels, or perhaps down regulation is
TLR dependent. During HSV-1 infections, IL-10 was
shown to control the production of immune mediators
by microglial cells and corneal immunopathology in
stromal keratitis [78–80]. Thus, the high levels of IL-10
mRNA observed in the TG of TLR2/9−/− mice could be
an attempt to control the exacerbated immune response
triggered by the cells that were attracted by the high
levels of MCP-1, whereas in the WT mice, its expression
could be sufficient to control the immune response trig-
gered by HSV-1. Surprisingly, increased levels of IL-5
mRNAs were observed in the TG of infected compared
to mock-infected TLR2/9−/− mice and also compared to
WT infected mice (Fig. 9b). IL-5 is an important compo-
nent of the Th2 immune response that is known to act
not only in response to extracellular parasites and aller-
gens but also in maintaining metabolic homeostasis and
tissue repair [81, 82]. Type 2 immune responses are also
known to play a regulatory role in limiting type 1 im-
mune responses and the extent of its damage, as well
[83]. IL-5, produced primarily by T helper type 2 cells
and mast cells, induces B cell differentiation into
antibody-producing cells and enhances the proliferation
and differentiation of eosinophils [84, 85]. However, the
production of IL-5 during an immune response can also
lead to tissue damage, mainly through the excess activity
of eosinophils [86, 87]. Therefore, the high IL-5 mRNA
levels in the TG of TLR2/9−/− infected mice could be
contributing to their ineffective immune response.
Conclusions
Altogether, this work has highlighted, among the studied
cells, the main cells (DCs, Mo/Mϕ, CD8+ T lympho-
cytes) that produce the molecules (IL-1β; iNOS, gran-
zyme B) in the key organ (TG) of the body that controls
the immune response against HSV-1. Additionally, it
was shown that, very early after infection, type I IFNs
(IFN-α and IFN-β) are expressed by cells in virus-in-
fected tissue and, also, that MCP-1 chemokine showed to
be important in the HSV-1 response, since it attracts the
immune cells to the site of infection. Beyond uncovering
more knowledge about the host response to HSV-1, these
data could help scientists develop efficient vaccines, treat-
ments or diagnostic and prognostic approaches for
HSV-1.
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Additional file 1: Figure S1. Representative FACS density plots
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showing the gate strategy for the identification of iNOS within F4/80+
gated on live CD45+ leucocytes in the trigeminal ganglia (a) and spleen
(b) from a single HSV1-infected WT mouse. A minimum of 100,000 events
was acquired for analysis. (PPTX 2700 kb)
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